Search Results
Pharmaceutical Business eJournal

83,021 Total downloads | Link to this page | Subscribe to this eJournal (requires login)

Viewing: 1 - 50 of 675 papers

1.

Killer Acquisitions

Journal of Political Economy, Vol. 129, No. 3, pp. 649–702, March 2021
Number of pages: 97 Posted: 12 Sep 2018 Last Revised: 02 May 2021
Accepted Paper Series
London Business School, Yale School of Management and Yale School of Management
Downloads 6,398
2.

The Globalization of Innovation: Pharmaceuticals: Can India and China Cure the Global Pharmaceutical Market

Number of pages: 67 Posted: 11 Jun 2008 Last Revised: 23 Feb 2014
Working Paper Series
Center for Entrepreneurship and Research Commercialization, Pratt School of Engineering, Cornell University - School of Industrial and Labor Relations, Duke University - Department of Sociology - Director, Center on Globalization, Governance & Competitiveness, Harvard University - Labor and Worklife Program and BusinessWeek
Downloads 2,873
3.

Unpatentable Drugs and the Standards of Patentability

Texas Law Review, Vol. 87, pp. 503-570, 2009
Number of pages: 68 Posted: 04 May 2008 Last Revised: 02 Jun 2013
Accepted Paper Series
affiliation not provided to SSRN
Downloads 1,933
4.

The COVID-19 Vaccine Race: Intellectual Property, Collaboration(s), Nationalism and Misinformation

Washington University Journal of Law and Policy, Vol. 64, 2020
Number of pages: 22 Posted: 25 Jul 2020
Accepted Paper Series
Saint Louis University - School of Law
Downloads 1,910
5.

Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem

New York University Law Review, Vol. 81, p. 1553, 2006, Columbia Law and Economics Working Paper No. 306
Number of pages: 68 Posted: 21 Oct 2006 Last Revised: 28 Dec 2013
Accepted Paper Series
New York University School of Law
Downloads 1,669
6.

May Your Drug Price Be Evergreen

Oxford Journal of Law and the Biosciences (2018)
Number of pages: 58 Posted: 31 Oct 2017 Last Revised: 28 Apr 2019
Accepted Paper Series
UC Hastings Law
Downloads 1,565
7.

Machine Learning with Statistical Imputation for Predicting Drug Approvals

Number of pages: 60 Posted: 25 May 2017 Last Revised: 21 May 2019
Working Paper Series
Massachusetts Institute of Technology (MIT) - Laboratory for Financial Engineering, Massachusetts Institute of Technology (MIT) - Laboratory for Financial Engineering and Massachusetts Institute of Technology (MIT) - Computer Science and Artificial Intelligence Laboratory (CSAIL)
Downloads 1,210
8.

Pharmaceutical Innovation

KSG Working Paper No. RWP07-004, AEI-Brookings Joint Center Working Paper No. 07-19
Number of pages: 59 Posted: 06 Feb 2007
Working Paper Series
Harvard University - Harvard Kennedy School (HKS)
Downloads 1,192
9.

The Indian Pharmaceutical Industry - an Overview of Internal Efficiencies Using Data Envelopment Analysis

Number of pages: 23 Posted: 11 May 2004
Working Paper Series
Indian Institute of Management (IIM), Calcutta and Indian Institute of Technology Kanpur
Downloads 1,008
10.

The Health Impact Fund: Better Pharmaceutical Innovations at Much Lower Prices

INCENTIVES FOR GLOBAL PUBLIC HEALTH: PATENT LAW AND ACCESS TO MEDICINES, Thomas Pogge, Matthew Rimmer, and Kim Rubenstein, (eds.), Cambridge: Cambridge University Press, 2010
Number of pages: 26 Posted: 09 Jul 2009
Accepted Paper Series
Yale Philosophy Department
Downloads 989
11.

The Drug Innovation Paradox

Missouri Law Review, Forthcoming, University of Missouri School of Law Legal Studies Research Paper No. 2017-12
Number of pages: 75 Posted: 07 Apr 2017 Last Revised: 09 May 2018
Accepted Paper Series
University of Missouri School of Law
Downloads 943
12.

COVIDSafe, Australia’s Digital Contact Tracing App: The Legal Issues

Number of pages: 13 Posted: 03 May 2020
Working Paper Series
La Trobe Law School
Downloads 902
13.

Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents

Number of pages: 35 Posted: 16 Jul 2003
Working Paper Series
University of Pennsylvania - The Wharton School and Office of Health Economics
Downloads 862
14.

Drug Wars: A New Generation of Generic Pharmaceutical Delay

Harvard Journal on Legislation, Vol. 53, 2016, UC Hastings Research Paper No. 155
Number of pages: 64 Posted: 11 Sep 2015 Last Revised: 20 Jun 2016
Accepted Paper Series
UC Hastings Law and University of California Hastings College of the Law
Downloads 854
15.

European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending

Number of pages: 38 Posted: 27 Sep 2006
Working Paper Series
University of Connecticut - Department of Finance and University of North Carolina (UNC) at Chapel Hill

Multiple version iconThere are 2 versions of this paper

Downloads 828
16.

Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978-2002

Review of Economics and Statistics, Vol. 89, No. 3, 2007
Number of pages: 18 Posted: 28 Oct 2007 Last Revised: 08 Jun 2014
Accepted Paper Series
Downloads 788
17.

The Invention of an Investment Incentive for Pharmaceutical Innovation

The Journal of World Intellectual Property (2012) Vol. 15, No. 5-6., pp. 1-60
Number of pages: 60 Posted: 20 Jan 2013 Last Revised: 19 Oct 2015
Accepted Paper Series
Nirma University - Institute of Law
Downloads 691
18.

Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies

ISID Working Paper No. 2006/05
Number of pages: 68 Posted: 02 Dec 2009
Working Paper Series
Central University of Gujarat

Multiple version iconThere are 2 versions of this paper

Downloads 628
19.

Physician Agency and Adoption of Generic Pharmaceuticals

Number of pages: 52 Posted: 02 Jul 2011
Working Paper Series
University of Tokyo
Downloads 613
20.

Patent Amendment Act 2005: Its Effect on Indian Pharmaceutical Company

Number of pages: 14 Posted: 17 Jul 2009
Working Paper Series
West Bengal National University of Juridical Sciences
Downloads 580
21.

AI on Drugs: Can Artificial Intelligence Accelerate Drug Development? Evidence from a Large-scale Examination of Bio-pharma Firms,

MISQ Forthcoming
Number of pages: 56 Posted: 20 Feb 2020 Last Revised: 26 May 2021
Accepted Paper Series
University of Connecticut - Operations & Information Management Department and University of Pennsylvania - The Wharton School
Downloads 578
22.

Global Drug Diffusion and Innovation with the Medicines Patent Pool

Number of pages: 96 Posted: 02 Aug 2019 Last Revised: 25 Apr 2021
Working Paper Series
Max Planck Institute for Innovation and Competition
Downloads 550
23.

Accounting Profitability and the Political Process: The Case of R&D Accounting in the Pharmaceutical Industry

Number of pages: 52 Posted: 29 Nov 2014 Last Revised: 28 Jan 2020
Working Paper Series
Lancaster University - Department of Accounting and Finance, Heinrich Heine University Dusseldorf - Duesseldorf Institute for Competition Economics (DICE) and WHU - Otto Beisheim School of Management
Downloads 535
24.

Pharmaceuticals, Political Money, and Public Policy: A Theoretical and Empirical Agenda

Journal of Law, Medicine and Ethics, Vol. 14, No. 3, 2013, Forthcoming
Number of pages: 26 Posted: 11 Jul 2013
Accepted Paper Series
University of Texas - Pan American
Downloads 526
25.

Legal Fallacies of Antipsychotic Drugs

Journal of the American Academy of Psychiatry and the Law, Vol. 35, p. 235, 2007
Number of pages: 12 Posted: 06 Dec 2006 Last Revised: 28 Mar 2008
Accepted Paper Series
affiliation not provided to SSRN, University of Rochester Medical Center, University of Rochester, University of Rochester Medical Center and Mendota Mental Health Institute
Downloads 524
26.

Valuation of Intangible Assets: Estimating Late-Stage Development Cost of Pharmaceutical R&D

Number of pages: 52 Posted: 12 Sep 2007
Working Paper Series
Institute of Leadership and Management in Health - Kingston University and Henley Management College - Henley Centre for Value Improvement (HCVI)
Downloads 524
27.

The TRIPS Agreement Article 73 Security Exceptions and the COVID-19 Pandemic

Research Paper 116, South Centre, Geneva (August 2020), FSU College of Law, Public Law Research Paper No. 930, FSU College of Law, Law, Business & Economics Paper No. 20-16
Number of pages: 40 Posted: 28 Aug 2020
Working Paper Series
Florida State University - College of Law
Downloads 523
28.

The COVID-19 Pandemic and the Challenge for Innovation Policy

Northern Ireland Legal Quarterly 71(1), 2020
Number of pages: 7 Posted: 15 Apr 2020 Last Revised: 29 Apr 2020
Accepted Paper Series
University of Melbourne - Law School and University of Bristol
Downloads 519
29.

Pharmaceutical Patent Enforcement: A Developmental Perspective

Number of pages: 33 Posted: 11 Dec 2014
Working Paper Series
Nirma University - Institute of Law, Independent and Independent
Downloads 511
30.

A Prescription for Excessive Drug Pricing: Leveraging Government Patent Use for Health

18 Yale J. L. & Tech. 275 (2016), Yale Law School, Public Law Research Paper No. 577, Yale Law & Economics Research Paper No. 560
Number of pages: 80 Posted: 03 Sep 2016 Last Revised: 21 Sep 2016
Accepted Paper Series
Hagens Berman Sobol Shapiro, Yale University - Law School, Independent and Yale University, Law School, Students
Downloads 501
31.

Entry and Competition in Generic Biologics

Managerial and Decision Economics, 2007
Number of pages: 39 Posted: 17 Jul 2007 Last Revised: 20 Sep 2014
Accepted Paper Series
Duke University - Department of Economics, Duke University - Fuqua School of Business and Duke University - Medical Center
Downloads 488
32.

The Effects of Detailing on Prescribing Decisions Under Quality Uncertainty

Quantitative Marketing and Economics, Vol.8, No. 2, pp.123-165, June 2010
Number of pages: 51 Posted: 29 Aug 2007 Last Revised: 06 Jul 2010
Accepted Paper Series
Johns Hopkins University - Carey Business School and New York University (NYU) - Leonard N. Stern School of Business
Downloads 466
33.

Pathways Across the Valley of Death: Novel Intellectual Property Strategies for Accelerated Drug Discovery

Yale Journal of Health Policy, Law, and Ethics, Vol. 8, No. 1, 2008
Number of pages: 37 Posted: 17 Jan 2008
Accepted Paper Series
Duke University School of Law, Duke University School of Law, The National Academies - National Academy of Sciences (NAS) and Independent
Downloads 465
34.

The War on Drugs: Estimating the Effect of Prescription Drug Supply-Side Interventions

Number of pages: 78 Posted: 07 Mar 2016 Last Revised: 08 Sep 2016
Working Paper Series
Brown University - Department of Economics
Downloads 462
35.

The Effects of Publicity on Demand: The Case of Anti-Cholesterol Drugs

Published in Marketing Science 35(1):158-181, 2016, Rotman School of Management Working Paper No. 1782055
Number of pages: 54 Posted: 09 Mar 2011 Last Revised: 08 May 2020
Working Paper Series
Johns Hopkins University - Carey Business School, HEC Montreal, University of Toronto - Rotman School of Management and York University
Downloads 452
36.

Distorted Drug Patents

95 Washington Law Review 1317 (2020), University of Missouri School of Law Legal Studies Research Paper No. 2019-20
Number of pages: 68 Posted: 30 Sep 2019 Last Revised: 02 Nov 2020
Accepted Paper Series
University of Missouri School of Law and Colorado College - Department of Economics & Business
Downloads 447
37.

Bayesian Sequential Learning for Clinical Trials of Multiple Correlated Medical Interventions

INSEAD Working Paper No. 2020/40/TOM/ACGRE
Number of pages: 57 Posted: 25 May 2018 Last Revised: 02 Sep 2020
Working Paper Series
INSEAD - Technology and Operations Management, University of Pennsylvania - Operations & Information Management Department and Indiana University Bloomington - Kelley School of Business
Downloads 442
38.

The Concept of an Agreement and Beyond: How to Block Parallel Imports of Pharmaceuticals to Protect the Heart of Competition

EC COMPETITION LAW A CRITICAL ASSESSMENT, Giuliano Amato, Claus-Dieter Ehlermann, eds., pp. 81-142, Hart Publishing, 2007
Number of pages: 62 Posted: 06 Dec 2007
Accepted Paper Series
European University Institute
Downloads 419
39.

Perverse Incentives: Why Everyone Prefers High Drug Prices -- Except for Those Who Pay the Bills

57 Harv. J. on Legis. 303 (2020)
Number of pages: 74 Posted: 18 Apr 2018 Last Revised: 21 Oct 2020
Accepted Paper Series
UC Hastings Law
Downloads 414
40.

Applications of Internet of Things in Pharmaceutical Industry

Number of pages: 14 Posted: 24 Aug 2019 Last Revised: 29 Aug 2019
Working Paper Series
University College of Engineering, Anna University - Bharathidasan Institute of Technology (BIT Campus), Anna University - Department of Pharmaceutical Technology and Anna University - Department of Pharmaceutical Technology

Multiple version iconThere are 2 versions of this paper

Downloads 391
41.

The U.S. Biologics Price Competition and Innovation Act of 2009 Triggers Public Debates, Regulatory/Policy Risks, and International Trade Concerns

Global Trade and Customs Journal, Vol. 6, No. 11 & 12, 2011
Number of pages: 34 Posted: 03 Nov 2011
Accepted Paper Series
The Kogan Law Group, P.C.
Downloads 390
42.

A 'Calibrated Approach': Pharmaceutical FDI and Evolution of the Patent Law in India

Number of pages: 19 Posted: 20 Nov 2007 Last Revised: 13 Mar 2013
Working Paper Series
Independent and U.S. International Trade Commission
Downloads 389
43.
Downloads 382
44.

Financing Drug Research: What are the Issues?

2008 Industry Studies Conference Paper
Number of pages: 28 Posted: 21 May 2008
Working Paper Series
Centre for Economic Policy Research (CEPR)
Downloads 381
45.

Optimal Supply Chain Structure for Distributing Essential Drugs in Low Income Countries: Results from a Randomized Experiment

Ross School of Business Paper No. 1269
Number of pages: 39 Posted: 28 Mar 2015
Working Paper Series
World Bank, World Bank - Development Research Group (DECRG), World Bank, Crown Agents and Harvard Medical School
Downloads 365
46.

Drug Rebates Do Not Increase Costs to Consumers

Number of pages: 8 Posted: 08 Jun 2018
Working Paper Series
DePaul University - Department of Economics and The Jack Kemp Foundation
Downloads 364
47.

Review of the Literature on Reference Pricing

Universitat Pompeu Fabra Economics WP No. 362
Number of pages: 49 Posted: 21 Jul 1999
Working Paper Series
Universitat Pompeu Fabra - Department of Economics and Business (DEB) and Universitat Pompeu Fabra - Faculty of Economic and Business Sciences
Downloads 339
48.

Fundamental Analysis of Pharmaceutical Companies

Number of pages: 21 Posted: 16 Nov 2019
Working Paper Series
UCD Michael Smurfit Graduate Business School
Downloads 333
49.

Generic Entry into a Regulated Pharmaceutical Market

iHEA 2007 6th World Congress: Explorations in Health Economics Paper
Number of pages: 25 Posted: 11 Jun 2007
Working Paper Series
Universitat Pompeu Fabra - Faculty of Economic and Business Sciences, Universitat Pompeu Fabra - Faculty of Economic and Business Sciences and University of Barcelona
Downloads 330
50.

Curbing Unfair Drug Prices: A Primer for States

Global Health Justice Partnership Policy Paper, August 2017
Number of pages: 24 Posted: 27 Nov 2017
Accepted Paper Series
Yale School of Public Health, Yale University, Law School, Students, Yale University, Law School, Students, Yale University, Law School, Students and Yale School of Public Health
Downloads 329